Skip to content

Should we spare the nukes? NRTI HIV drugs may impair success of hepatitis C treatment

Hepatitis B hasn’t gone away – and may come back

`Shock and kill` approach awakens latent HIV in test tube

Over 3000 children diagnosed with HIV in Lusaka after hospital introduces opt-out HIV testing

Pooled procurement may not deliver lower ARV prices

High viral load and low CD4 cell count risk factors for non-HIV-related illnesses

Hepatitis B may increase all-cause mortality in HIV-positive people, according to meta-analysis

Meeting the non-medical needs of people with HIV in England: document sets ambitious goals

Nelfinavir treatment has no effect on risk of cancers